Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02815059
Title Study of Pts With Philadelphia Chromosome-Pos ALL With Comb of Ibrutinib, Dasatinib, and Prednisone
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Utah
Indications

acute lymphoblastic leukemia

Therapies

Dasatinib + Ibrutinib + Prednisone

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.